Table 2 Sero-prevalence of Chlamydia pneumoniae and heat shock proteins 60 in the various age groups
Male N(%) | Female N(%) | All N(%) | |
|---|---|---|---|
N = 1030 | Chlamydia pneumoniae (IgA) positive | ||
Age groups | |||
30–49 | 45 (34.4) | 7 (46.7) | 52 (35.6) |
50–59 | 104 (39.4) | 9 (25.0) | 113 (37.7) |
60–70 | 184 (38.3) | 36 (34.3) | 220 (37.7) |
p = 0.5 | p = 0.8 | P = 0.9 | |
All | 333 (38.1) | 52 (33.3) | 385 (37.4) |
N = 1030 | Chlamydia pneumoniae (IgG) positive | ||
Age groups | |||
30–49 | 41 (31.5) | 6 (40.0) | 47 (32.4) |
50–59 | 109 (41.1) | 13 (36.1) | 122 (40.5) |
60–70 | 193 (40.3) | 43 (41.0) | 236 (40.4) |
p = 0.2 | p = 0.9 | p = 0.2 | |
All | 343 (39.2) | 62 (39.7) | 405 (39.3) |
N = 1029 | Chlamydia heat shock protein 60 positive | ||
Age groups | |||
30–49 | 26 (20.0) | 2 (13.3) | 28 (19.3) |
50–59 | 52 (19.7) | 7 (19.4) | 59 (19.7) |
60–70 | 114 (23.8) | 27 (25.7) | 141 (24.1) |
p = 0.4 | p = 0.2 | p = 0.2 | |
All | 192 (21.9) | 36 (28.1) | 228 (22.2) |
N = 983 | Human heat shock protein 60 positive | ||
Age groups | |||
30–49 | 13 (10.5) | 1 (7.1) | 14 (10.1) |
50–59 | 22 (8.9) | 5 (13.9) | 27 (9.5) |
60–70 | 37 (8.0) | 5 (5.0) | 42 (7.5) |
p = 0.4 | p = 0.2 | p = 0.5 | |
All | 72 (8.7) | 11 (7.3) | 83 (8.4) |